Syndeio Biosciences
Rob Houghtaling is an experienced professional in the biotechnology and life sciences sectors, currently serving as the Head of Corporate Development at Syndeio Biosciences since January 2019, focusing on clinical-stage therapeutics for neuropsychiatric disorders. Additionally, Rob is the Founder and Principal of Morningview Life Sciences, offering independent consulting for early-stage biotech companies. Past roles include positions in strategy and business development at Psy Therapeutics and Scioto Biosciences, as well as advisory services at Locust Walk and Health Advances. Rob holds a Master's degree in Biomedical Engineering from Columbia University and a Bachelor's degree in Biomedical Engineering from the University of Virginia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices